Cipla, one of the largest domestic pharmaceutical companies, has posted a staggering 72.60 per cent rise in net profit at Rs 241.71 crore during the first quarter ended June 30, 2009, as compared to Rs 140.04 crore in the corresponding quarter of the previous fiscal.
Total income of the company increased from Rs 1,224.14 crore to Rs 1,388.01 crore.
The company’s stocks settled at Rs 275, down 2.8 per cent on the BSE today.